title: Leishmaniasis, lupus nephritis and immunosuppressive therapy.
authors: From the Systemic Autoimmune Diseases Unit, Internal Medicine Department, joseantoniovh@hotmail.com.
authors: J A
authors: JA
authors: Vargas-Hitos
authors: From the Systemic Autoimmune Diseases Unit, Internal Medicine Department.
authors: R
authors: R
authors: Roa-Chamorro
authors: From the Systemic Autoimmune Diseases Unit, Internal Medicine Department.
authors: J M
authors: JM
authors: Sabio
authors: Infectious Diseases Department and.
authors: R
authors: R
authors: Javier-Martínez
authors: Histopathology Department, Virgen de las Nieves, University Hospital, Granada, Spain.
authors: A
authors: A
authors: Martín-Castro
authors: From the Systemic Autoimmune Diseases Unit, Internal Medicine Department.
authors: J
authors: J
authors: Jiménez-Alonso
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018314:Leishmania infantum; D007896:Leishmaniasis / Q000188:drug therapy / Q000473:pathology*; D008181:Lupus Nephritis / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000981:Antiprotozoal Agents; D007166:Immunosuppressive Agents; D000666:Amphotericin B; D009173:Mycophenolic Acid